LncRNAs can influence the transcription of tumour‐related genes by altering epigenetic modifications or regulating enhancers.12 A few lncRNAs are revealed to act as tumour suppressors that regulate cancer signalling pathways such as p53 tumour suppressor signalling.13 Therefore, lncRNAs may be great biomarkers in clinical diagnosis and provide effective potential targets in future cancer therapies. The gene discussed is TP53; the disease is cancer.